News from the BioRegion STERN

Here you'll find all press releases and news from companies and institutes in the STERN BioRegion.

10/31/2019 | Atriva Therapeutics GmbH

Atriva Therapeutics präsentiert auf der BIO-Europe in Hamburg

Tübingen, 31. Oktober 2019 – Das biopharmazeutische Unternehmen Atriva Therapeutics GmbH, ein Vorreiter bei der Entwicklung von gegen Wirtszellen gerichteten antiviralen Therapien, wird sich auf der 25. jährlichen internationalen Partnering-Konferenz BIO-Europe® präsentieren.
Handshake between Michael J. Collins (CEM) and Dr. Steffen Huettner (Intavis).
10/29/2019 | Intavis AG

CEM Corporation acquires key assets of Intavis Bioanalytical Instruments

Matthews, N.C. October 25th, 2019 – CEM Corporation today announced that it has entered into a definitive agreement to purchase the instrumentation lines of Intavis Bioanalytical Instruments AG, with headquarters in Cologne Germany. The acquisition allows CEM to strengthen its product offering in the Life Sciences for proteomics, in-situ hybridizat...
10/28/2019 | Curetis GmbH

Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test

Curetis N.V. (the "Company" and, together with its subsidiaries, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced that its fully-owned subsidiary Ares Genetics has launched an early access program for its novel, artificial intelligence (AI) powered, next-generation sequencing (NGS) based molecular antibiotic sus...
FOCUS label Growth Champion 2020
10/17/2019 | Bentley InnoMed GmbH

Hechinger Medizintechnikunternehmen Bentley ist FOCUS Wachstumschampion 2020

Die Erfolgsgeschichte geht weiter. Nachdem Bentley erst im Sommer dieses Jahres sein zehnjähriges Bestehen gefeiert hat, steht nun das nächste Highlight in der kurzen Firmengeschichte an. Das Hechinger Medizintechnikunternehmen wurde zum FOCUS Wachstumschampion 2020 gekürt. Gemeinsam mit Statista, einem der weltweit größten Online-Statistik-Portale...
10/15/2019 | DEKRA SE

DEKRA Becomes First Notified Body in Europe for In-Vitro Diagnostics under New IVD Regulation

DEKRA has become the first certification company to be recognized as a Notified Body by the European Commission under the new EU regulation on in-vitro diagnostics. Under this new regulation, considerably stricter requirements will apply to manufacturers of in-vitro diagnostics (IVDs) in the European Union starting from May 26, 2022. IVDs are medic...
09/27/2019 | Insilico Biotechnology AG

Insilico and Janssen take another step towards predictive biomanufacturing: Digital Twins allow for accelerated timelines in cell line development for biologics production

Insilico Biotechnology AG and the Janssen Pharmaceutical Companies of Johnson & Johnson announced an agreement to apply Insilico's predictive Digital Twins for the early selection of high-performing cells to further boost efficiency and throughpu...
09/16/2019 | Curetis GmbH

CuretisGroup Subsidiary Ares Genetics Signs R&D and Option Agreement with Leading Global IVD Corporation

R&D collaboration to develop NGS-based predictive antibiotic resistance testing powered by ARESdb, Partner to fund R&D and obtains option to license ARESdb and ARES Technology Platform for human clinical diagnostic use
09/13/2019

Partners from across Europe to host event in Galway to support companion diagnostics SMEs

WestBIC, CÚRAM, the Science Foundation Ireland Research Centre for Medical Devices at NUI Galway, and their European partners in Codex4SMEs Information and Networking Event are to host the Interreg North-West Europe project Codex4SMEs (Companion Diagnostics Expedited for Small and Medium-sized Enterprises) on Wednesday, 18 September, at Hotel Meyri...
09/04/2019 | Atriva Therapeutics GmbH

Atriva Therapeutics nimmt in den kommenden Monaten an vier Konferenzen teil

Das biopharmazeutische Unternehmen Atriva Therapeutics GmbH, ein Vorreiter bei der Entwicklung von gegen Wirtszellen gerichteten antiviralen Therapien, gab heute gab heute die Teilnahme an vier Partnering-Konferenzen bekannt, die in den nächsten Monaten weltweit stattfinden.  
08/28/2019 | immatics biotechnologies GmbH

Immatics and Celgene Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies

Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting cancer immunotherapies, today announced that Immatics and Celgene Corporation have entered into a strategic collaboration and option agreement to develop novel adoptive cell therapies targeting multiple cancers.
A person wearing a purple-colored pair of gloves inserts the thin cannula of a syringe into the organ-on-a-chip system.
08/27/2019 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

Retina-on-a-Chip: Aussagekräftiges Modell zur Untersuchung von Augenerkrankungen und Medikament-Nebenwirkungen

Mithilfe der neuartigen Organ-on-a-Chip-Technologie ist es Wissenschaftlern des Fraunhofer-Instituts für Grenzflächen- und Bioverfahrenstechnik IGB und der Eberhard Karls Universität Tübingen gelungen, die Komplexität der menschlichen Netzhaut in einem mikrophysiologischen System nachzubilden. Die Retina-on-a-Chip kann helfen, Augenerkrankungen zu ...
08/13/2019 | CureVac AG

CureVac schließt exklusive Forschungskooperation mit der Yale-Universität zur Erforschung mRNA-basierter Arzneimittelkandidaten für die Behandlung von Lungenerkrankungen

Das biopharmazeutische Unternehmen CureVac AG, Pionier im Bereich mRNA-basierter Impfstoffe und Therapeutika, gab heute den Abschluss einer Forschungskooperation mit der Yale-Universität bekannt. Gegenstand dieser Vereinbarung ist die Identifikation ...
08/13/2019 | Insilico Biotechnology AG

Predictive Digital Twins control bioprocesses for the production of monoclonal antibodies

Insilico Biotechnology AG and the Laboratory of Systems Theory and Automatic Control at the Institute for Automation Engineering (IFAT) of the Otto von Guericke University Magdeburg started a joint project on model predictive control (MPC) for the production of monoclonal antibodies in mammalian cell culture processes using Insilico's Digital Twins...
08/12/2019 | Curetis GmbH

Curetis Retains H.C. Wainwright & Co. as Strategic Advisor

Curetis N.V. (the "Company" and, together with its subsidiaries, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced that it has retained the U.S. based investment bank, H.C. Wainwright & Co., LLC, as strategic advisor in an  effort to assess all available strategic and tactical options going forward to po...
08/08/2019 | Curetis GmbH

Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing

Curetis N.V. (the "Company" and, together with its subsidiaries, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced that its wholly-owned subsidiary Ares Genetics GmbH has opened a specialized service laboratory offeringnext-generation molecular antimicrobial resistance (AMR)testing services with an initial focus ...
07/19/2019 | immatics biotechnologies GmbH

Immatics Presents First Cohort Data on the ACTolog® Personalized Multi-Target Cell Therapy Trial Demonstrating Safety and T-cell Persistence in Treated Cancer Patients

Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting cancer immunotherapies, announced today a comprehensive data set having completed the first cohort of the ACTolog®...
07/17/2019 | Atriva Therapeutics GmbH

Atriva Therapeutics erhält EU-Förderung zur Biomarker-Validierung

Atriva Therapeutics erhält als eines von vier Unternehmen den Biomarker Validation Award - Ziel ist die Validierung des Biomarkers zum Monitoring der MEK-Inhibition durch die Influenza-Therapie ATR-002, die derzeit in Phase I geprüft wird - Fördersumme wird als Laborleistung der Integrated Biobank of Luxembourg vergeben  
07/12/2019

Towards personalized medicine: 5 West-Holland companies get support from Codex4SME’s

The Interreg project Codex4SMEs (Companion diagnostics expedited for small and medium-sized businesses) project plans to improve healthcare by enhanced adoption of Personalized Medicine in North-West Europe. The objective is to establish a network, which supports SMEs along the value chain of Companion diagnostics (Cdx) development.
07/08/2019 | immatics biotechnologies GmbH

Immatics Appoints Harpreet Singh as Chief Executive Officer

Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical Company active in the discovery and development of T-cell redirecting cancer immunotherapies, today announced that Harpreet Singh has been appointed the Company’s Chief Executive Officer (CEO).
07/04/2019 | Curetis GmbH

Curetis Group Company Ares Genetics is Granted Key European Patent on Genetic Resistance Testing

Patent broadly covers genetic biomarkers and biomarker combinations indicating antibiotic resistance, First of eleven similar patents filed covering various pathogen/drug combinations, Strengthens unique position of ARESdb, Ares Genetics’ knowledgebase of antimicrobial resistance genetics